Vermillion Closes $20.6 Million Equity Financing

Vermillion (formerly Ciphergen Biosystems), a Fremont, CA-based molecular diagnostics firm, has closed a $20.6 million equity financing with new and existing investors. The financing, which comes two weeks after the company received a non-compliance letter from Nasdaq, will be used to further...

Indiana Seed Fund Invests in FlowCo

Indiana’s only life sciences seed-stage fund has invested $250,000 in FlowCo, a local company that’s developing a device that helps size and deliver stents more accurately. The company will use the money to create a human-use prototype for clinical trials scheduled to take place by next...

CryoCor Completes Enrollment of A-Fib Trial

San Diego-based CryoCor has completed enrollment of the pivotal clinical study for using its Cryoabalation System to treat atrial fibrillation, bringing the company one step closer to its goal of U.S. approval for both a-fib and atrial flutter. The Cryoabalation System, which uses extreme cold to destroy...

Presenters Selected for AdvaMed 2007

AdvaMed, the industry trade association, has selected 22 emerging med tech companies to present at an inaugural conference, developed in part to create networking and partnering opportunities for its smaller member companies. The event, AdvaMed 2007, will be held October 1-3 in Washington, D.C., and will...

Pittsburgh Partnership Backs Three Up and Comers

The Pittsburgh Life Sciences Greenhouse (PLSG), a public/private partnership founded in 2001 to grow Southwestern Pennsylvania’s life sciences industry, has added two local companies — Separation Design Group and ThermalTherapeutics Systems — to its expanding investment portfolio and...

A+ for Mirabilis Medica

Mirabilis Medica, a three-year old startup based in Bothell, WA, has closed a $10.5 million extension to the Series A financing it completed a year ago. The funding — led by Arboretum Ventures of Ann Arbor, MI, and participated in by Split Rock Partners, Dow Venture Capital, and an individual investor...

Signalife Completes $102 Million Financing

Signalife, a Greenville, SC, firm specializing in biomedical signal monitoring, has completed $102 million in financing — a much anticipated boost following the company’s June receipt of an AMEX deficiency letter stating that stockholder equity had fallen below the requirement for companies with...

Minrad Appoints Two Senior Execs

Minrad, of Orchard Park, NY, today announced two senior-level appointments. Dennis Goupil was named senior vice president technical and Terence Vollrath was appointed vice president of operations. Goupil joins Minrad from Biocure,  an early stage medical device company based in Norcross, GA, where he was...